[
  {
    "ts": null,
    "headline": "Dividend Watch: Three Companies Boosting Quarterly Payouts",
    "summary": "Earnings season continues to move at a rapid pace, with many companies reporting daily. And recently, these three companies delivered news of higher dividend payouts.",
    "url": "https://finnhub.io/api/news?id=177e1500fcd85902845a9fa40bcf67982662278e47b428e543c518116c2cfe4d",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1731016020,
      "headline": "Dividend Watch: Three Companies Boosting Quarterly Payouts",
      "id": 131177664,
      "image": "https://media.zenfs.com/en/zacks.com/72e92f2def8e0975361faddc09fe1438",
      "related": "ABBV",
      "source": "Yahoo",
      "summary": "Earnings season continues to move at a rapid pace, with many companies reporting daily. And recently, these three companies delivered news of higher dividend payouts.",
      "url": "https://finnhub.io/api/news?id=177e1500fcd85902845a9fa40bcf67982662278e47b428e543c518116c2cfe4d"
    }
  },
  {
    "ts": null,
    "headline": "RHHBY or ABBV: Which Is the Better Value Stock Right Now?",
    "summary": "RHHBY vs. ABBV: Which Stock Is the Better Value Option?",
    "url": "https://finnhub.io/api/news?id=e611eacf3bf5c9ac56f8a875c56b3c0e057034f811a7b475366946bfe914e700",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1730997613,
      "headline": "RHHBY or ABBV: Which Is the Better Value Stock Right Now?",
      "id": 131177375,
      "image": "https://media.zenfs.com/en/zacks.com/45c083e4721b0d0d1f6e431ec0bb5cc1",
      "related": "ABBV",
      "source": "Yahoo",
      "summary": "RHHBY vs. ABBV: Which Stock Is the Better Value Option?",
      "url": "https://finnhub.io/api/news?id=e611eacf3bf5c9ac56f8a875c56b3c0e057034f811a7b475366946bfe914e700"
    }
  },
  {
    "ts": null,
    "headline": "AbbVie Inc. stock outperforms competitors despite losses on the day",
    "summary": "AbbVie Inc. stock outperforms competitors despite losses on the day",
    "url": "https://finnhub.io/api/news?id=082bdcc612d4f82673547600c37410f1b5c1585c292811ede022782479b951a2",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1730997300,
      "headline": "AbbVie Inc. stock outperforms competitors despite losses on the day",
      "id": 131190652,
      "image": "",
      "related": "ABBV",
      "source": "MarketWatch",
      "summary": "AbbVie Inc. stock outperforms competitors despite losses on the day",
      "url": "https://finnhub.io/api/news?id=082bdcc612d4f82673547600c37410f1b5c1585c292811ede022782479b951a2"
    }
  },
  {
    "ts": null,
    "headline": "Allergan Aesthetics Celebrates Annual BOTOX® Cosmetic (onabotulinumtoxinA) Day",
    "summary": "Allergan Aesthetics, an AbbVie company (NYSE: ABBV), announced that the sixth annual BOTOX® Cosmetic Day will be Wednesday, November 20. This holiday continues to celebrate the health care providers and patients that have made BOTOX® Cosmetic the number one selling neurotoxin globally.2 Following its recent FDA approval for the temporary improvement in the appearance of moderate to severe vertical bands connecting the jaw and neck (platysma bands) in adults, BOTOX® Cosmetic is now the first and",
    "url": "https://finnhub.io/api/news?id=9184aa8d63fa9c6d5ae841432b18cf60d69ca6cc6841ea444ab5dc3dbea88854",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1730984400,
      "headline": "Allergan Aesthetics Celebrates Annual BOTOX® Cosmetic (onabotulinumtoxinA) Day",
      "id": 131182491,
      "image": "https://media.zenfs.com/en/prnewswire.com/4f9d1143963702ee3b7daafe1d9ac46f",
      "related": "ABBV",
      "source": "Yahoo",
      "summary": "Allergan Aesthetics, an AbbVie company (NYSE: ABBV), announced that the sixth annual BOTOX® Cosmetic Day will be Wednesday, November 20. This holiday continues to celebrate the health care providers and patients that have made BOTOX® Cosmetic the number one selling neurotoxin globally.2 Following its recent FDA approval for the temporary improvement in the appearance of moderate to severe vertical bands connecting the jaw and neck (platysma bands) in adults, BOTOX® Cosmetic is now the first and",
      "url": "https://finnhub.io/api/news?id=9184aa8d63fa9c6d5ae841432b18cf60d69ca6cc6841ea444ab5dc3dbea88854"
    }
  }
]